Related Experiment Video
Updated: Jun 16, 2026

Development of Compendium for Esophageal Squamous Cell Carcinoma
Published on: April 12, 2024
Nomenclature evolution: Changes in the ISCN from the 2005 to the 2009 edition.
A R Brothman1, D L Persons, L G Shaffer
1Departments of Pediatrics, Human Genetics and Pathology and ARUP Institute for Clinical and Experimental Pathology, University of Utah School of Medicine, Salt Lake City, USA. art.brothman@genetics.utah.edu
The International System for Human Cytogenetic Nomenclature (ISCN) 2009 update introduces new guidelines for describing chromosomal abnormalities. This review guides cytogeneticists in adopting the revised nomenclature for accurate reporting of findings.
Area of Science:
- Cytogenetics
- Genetics
- Molecular Biology
Background:
- The International System for Human Cytogenetic Nomenclature (ISCN) provides standardized guidelines for reporting chromosomal abnormalities.
- Previous versions of ISCN have been crucial for consistent communication in cytogenetics research and clinical diagnostics.
- The ISCN 2005 version served as the standard for human cytogenetic nomenclature prior to the latest revision.
Purpose of the Study:
- To highlight key changes in the ISCN 2009 nomenclature compared to the ISCN 2005 version.
- To provide a practical guide for cytogeneticists transitioning to the new ISCN 2009 guidelines.
- To ensure accurate and consistent reporting of cytogenetic and molecular cytogenetic findings.
Main Methods:
- Comparative analysis of ISCN 2009 and ISCN 2005 guidelines.
- Focus on revisions to idiograms and specific chapter updates within the ISCN 2009 document.
- Review of changes impacting the description of cytogenetic and molecular cytogenetic findings.
Main Results:
- The ISCN 2009 introduces multiple modifications to existing nomenclature rules.
- Significant updates are noted in the idiogram representations and specific nomenclature chapters.
- The revised guidelines impact the standardized reporting of chromosomal variations.
Conclusions:
- The ISCN 2009 represents a significant update to human cytogenetic nomenclature.
- Adherence to ISCN 2009 is essential for precise communication in clinical and research settings.
- This review facilitates the adoption of the updated nomenclature for improved cytogenetic reporting.
More Related Videos
08:16Isotropic Light-Sheet Microscopy and Automated Cell Lineage Analyses to Catalogue Caenorhabditis elegans Embryogenesis with Subcellular Resolution
Published on: June 6, 2019
04:04Transauricular Vagus Nerve Stimulation and Electroencephalographic Assessment in Disorders of Consciousness
Published on: July 11, 2025
Related Concept Videos
Nomenclature of Aromatic Compounds with a Single Substituent
Nomenclature of Aromatic Compounds with Multiple Substituents
For disubstituted benzene derivatives, with two groups attached to the benzene ring, three constitutional isomers are possible. For example, consider dimethyl benzene, often called xylene, where the second methyl group can be substituted at the second, third, or fourth carbon. The relative position of the substituents is represented by prefixes ortho, meta, or...
Drug Nomenclature
Nomenclature of Secondary and Tertiary Amines
Nomenclature of Aryl and Heterocyclic Amines
Coordination Compounds and Nomenclature